Accelerate Diagnostics, Inc. (AXDX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jack Phillips | CEO, President & Director | 595k | -- | 1966 |
| Mr. David Patience | Chief Financial Officer | 285.27k | -- | 1986 |
| Mr. Lawrence Michael Mertz | Chief Technology Officer | 335.94k | -- | 1963 |
| Ms. Maya Gowri | Senior VP & Head of Operations | -- | -- | -- |
| Laura Pierson | Investor Relations Officer | -- | -- | -- |
| Mr. John Meduri | Chief Strategy Officer | -- | -- | -- |
| Mr. Chris Thode | Senior Vice President of US Commercial | -- | -- | -- |
| Ms. Rita Boukamel | Senior VP & Head of EMEA | -- | -- | -- |
Accelerate Diagnostics, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 134
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Corporate Governance
Recent Events
- May 13, 202410-Q: Periodic Financial ReportsSee Full Filing
- May 10, 20248-K/A: Corporate Changes & Voting MattersSee Full Filing
- May 08, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Apr 30, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Apr 11, 2024DEF 14A: Proxy StatementsSee Full Filing